This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
QUICK READ: Reaching physicians with key brand messages isn’t hard, but the online landscape has become crowded with many players. By far, Medscape is still number one in physician reach , and medical journal advertising has been proven to result in more branded Rx’s. Manhatten Research Taking The Pulse 2017.
But, will physicians tell patients that results depend on lifestyle intervention and a low-calorie diet? The drug carries a potential risk for a type of thyroid tumor and has a boxed warning. We are an obese country, and diabetes is getting worse.
As pharma reps’ access to physicians continues to decline, this case study examines the effectiveness of reaching physicians through other means—the EHR. Today’s physicians struggle to balance the increasing demands of patient loads, electronic health record (EHR) systems, and time spent on administrative tasks. THE CHALLENGE.
In September 2017, Amgen announced that it reached a global settlement with AbbVie, scheduling Amjevita’s American launch for January 31, 2023. Even some physicians remain hesitant about biosimilars in general. Temporary first-to-market advantage. Biosimilar uptake could be more gradual.
Over-the-Counter (OTC) and Prescription (Rx) brands have invested over $3 billion in linear TV advertising during the first half of 2022, with no signs of letting up. Xyzal —which launched in 1995 but entered the OTC market in 2017—found success with a creative that debuted in February. Affordability is key for Rx advertisers.
The Stockholm region in Sweden attempted this by developing a “Wise List” of medicines between 2017 and 2021, which enables physicians to select the least environmentally harmful product from those with equivalent efficacy. German College of General Practitioners and Family Physicians (DEGAM). Internet] NHS England.
Regression results showed that chronic loneliness was significantly and positively associated with physician visits. How can physicians identify people who are lonely and high risk for other health issues as a result? In a 2017 AARP study, the cost to Medicare of social isolation and loneliness was estimated at $6.7
In 2017, the US Food and Drug Administration (FDA) broke ground by approving the first drug with an embedded biosensor to track its use. Such information can then be used to inform the physician that if a particular patient’s data is not in a particular range, then that’s likely due to adherence issues, he explains.
The approval makes Relyvrio (sodium phenylbutyrate and taurursodiol) the first new therapy option for ALS – also known as motor neuron disease (MND) – since Mitsubishi Tanabe Pharma’s intravenous Radicava (edaravone) was cleared by the FDA in 2017. An oral version of edaravone was cleared this year.
based physicians reveals that a majority are concerned and confused about what constitutes a life-threatening emergency that would make an abortion procedure legal in those 11 states where it has been banned. Patient Pages: Patients Refuse Prescription Use After Recalls. Doctor Docs: Doctors Left Concerned After Roe v. Wade Overturn.
Since the government first created a Part D benefit with the Medicare Modernization Act of 2003 (MMA) , Democrats have agitated for greater governmental input into the cost of prescription drugs for Medicare beneficiaries. Such a change would sharply increase the number of people covered under this program.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content